Latest News and Press Releases

Serum Proteomic Test Could Optimize Treatment by Identifying Patients Unlikely to Benefit from Immunotherapy BOULDER, Colo. and MUNICH, Germany, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Biodesix®...

BOULDER, Colo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Biodesix today announced newly published data showing the noninvasive BDX-XL2 test, currently in development, could reduce the number of...

BOULDER, Colo., Aug. 29, 2018 (GLOBE NEWSWIRE) -- A new study published in The Oncologist demonstrates the objective prognostic value of the Biodesix VeriStrat® test in patients with non-small cell...

TAMPA, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- Bronchoscopy professionals in the United States need greater educational and practice-building support to ensure continued delivery of high-quality care...

TAMPA, Fla., May 15, 2018 (GLOBE NEWSWIRE) -- The Society for Advanced Bronchoscopy (SAB) will hold its second meeting, “Hot Topics in Advanced Bronchoscopy,” on Sunday, May 20th at the Hotel...

- First Data Showing Prognostic Value of Test Among Patients by Performance Status Presented at ACMQ Annual Meeting –  - Optimizing Best Supportive Care and Avoiding Overtreatment Creates an Expected...

BOULDER, Colo., April 18, 2018 (GLOBE NEWSWIRE) -- Biodesix®, Inc. is presenting new data today demonstrating the ability of the company’s droplet digital PCR (ddPCR™)-based platform to reliably...

BOULDER, Colo., April 05, 2018 (GLOBE NEWSWIRE) -- Biodesix®, Inc. will present new data confirming the ability of the company’s droplet digital PCR (ddPCR™)-based platform to reliably detect key...

BOULDER, Colo., March 20, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate...

BOULDER, Colo., March 05, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc., a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology, today...